# Skin & Aesthetics Peptide FAQ — GLOW & Melanotan II — Peptide Rejuvination

> Frequently asked questions about two Skin & Aesthetics research peptides — GLOW and Melanotan II — answered from the peer-reviewed literature and case reports, with citations.

Direct, citation-anchored answers to the questions most often asked about GLOW and Melanotan II.

## What is GLOW peptide?

GLOW is not a single peptide — it is a co-formulated research blend of three separate peptides: GHK-Cu (a copper-carrying tripeptide), BPC-157 (a gastric-derived pentadecapeptide), and TB-500 (a fragment of thymosin beta-4). Each has its own research literature; the combination itself has not been tested in a controlled study [1].

## What does the GLOW peptide do?

Each constituent contributes a different action: GHK-Cu stimulates collagen, elastin and glycosaminoglycan synthesis in skin [4][5]; BPC-157 promotes new blood-vessel growth and has accelerated tendon healing in animal studies [3][6]; TB-500 promotes cell migration and wound re-epithelialization [7]. Together, the combination thesis is that these three actions — matrix-building, vascular, and cell-mobility — support skin and tissue repair, though that combined claim has not itself been studied.

## What does GLOW peptide have in it?

A commonly cited research-label formulation lists GHK-Cu, BPC-157 and TB-500 at an approximate 50 mg / 10 mg / 10 mg ratio, though exact ratios are not standardized and vary by supplier.

## What peptides are in the GLOW blend?

Three: GHK-Cu (glycyl-L-histidyl-L-lysine copper complex), BPC-157 (sequence GEPPPGKPADDAGLV), and TB-500 (the acetylated heptapeptide Ac-LKKTETQ, a fragment of thymosin beta-4).

## What is Melanotan 2?

Melanotan II is a synthetic, cyclic seven-amino-acid analog of alpha-melanocyte-stimulating hormone (alpha-MSH), engineered for greater potency and enzymatic stability than the natural hormone. It is a non-selective agonist of the melanocortin receptor family (MC1R-MC5R) and has never been approved by the FDA or any other regulator [11].

## What is Melanotan 2 used for in research?

Controlled human and animal research has studied Melanotan II for skin/hair pigmentation (via MC1R), appetite suppression (via central MC3R/MC4R activity in reward circuitry) [9], and male erectile function — a placebo-controlled crossover trial found it produced clinically apparent erections in 8 of 10 men with psychogenic erectile dysfunction [12]. It is not approved for any of these uses.

## How does Melanotan 2 work in the body?

It activates MC1R on melanocytes, triggering a cAMP-PKA-CREB-MITF signaling cascade that upregulates the enzyme tyrosinase and shifts pigment synthesis toward darker eumelanin. Because it is non-selective, it also activates MC3R and MC4R in the brain, which is the documented mechanism behind its effects on appetite and sexual arousal [9][12].

## What is the melanogenesis (MC1R-cAMP-MITF) signaling cascade?

It is the chain of events by which melanocytes produce pigment: a signal (natural alpha-MSH, or a synthetic analog like Melanotan II) binds MC1R on the melanocyte surface, raising intracellular cAMP; cAMP activates protein kinase A (PKA), which activates the transcription factor CREB; CREB increases production of MITF, the master regulator of pigment genes; MITF then upregulates tyrosinase, the enzyme that drives melanin production, shifting the balance toward the darker eumelanin pigment.

## Is GLOW FDA-approved?

No. GLOW is not an FDA-approved drug product. Among its constituents, topical Copper Tripeptide-1 (GHK-Cu) is a legal cosmetic ingredient, but BPC-157 and TB-500 are unapproved research chemicals; in 2023 the FDA placed BPC-157 among bulk substances it identified as not eligible for pharmacy compounding pending further evaluation.

## Is Melanotan II legal for research use, and is it safe?

Melanotan II is sold by research suppliers for laboratory use only; it is not approved for human use by the FDA or any other regulator [11], and product sold outside a clinical-trial setting cannot be verified for identity, purity, or sterility. 'Safe' is not a word this desk can apply to it: published case reports document new or changing moles, renal injury, and priapism among people using it [8][10], alongside the appetite- and libido-altering effects documented in controlled studies [9][12].

## What is the difference between GLOW and Melanotan II?

GLOW is a three-peptide combination aimed at skin and tissue structure — collagen, blood vessels, and cell migration. Melanotan II is a single engineered molecule aimed at skin pigment through the melanocortin receptor family, with effects that extend to appetite and sexual function because that receptor family is not confined to skin. They are studied for different things, through different mechanisms, and neither is an approved medicine.

---

A clinician's-briefing digest of skin-remodeling and pigmentation research peptides — no products, no prescriptions, just the literature.